Advances in technology are changing the future of medicine

In this October, we are having the most important allergy festival in Asia-Pacific region the Joint Congress of Asia Pacific Association of Allergy, Asthma, and Clinical Immunology (APAAACI) and Asia Pacific Association of Pediatric Allergy, Respiratory, and Immunology in Kuala Lumpur, Malaysia (October 17–20, 2016, http://www.apaaaci-kl2016.org). The Joint Congress will be hosted by the Malaysian Society of Allergy and Immunology. “The Era of Allergy: Local and Global Insights and Intervention” is the main theme which will make the congress scientifically meaningful. There will be special sessions such as ‘commemorating 50 years since discovery of IgE. It is remarkable that new International Classification of Diseases (ICD)-11 beta phase structure “Allergic and hypersensitivity conditions” section has been constructed as a result of a detailed and careful action plan based on scientific evidences for the necessity of changes and collaboration with the World Health Organization ICD-11 revision governance [1]. APAAACI is supporting this international collaboration with the World Allergy Organization, the American Academy of Allergy Asthma and Immunology, the European Academy of Allergy and Clinical Immunology, the Latin American Society of Allergy, Asthma and Immunology, and the American College of Allergy Asthma and Immunology [2, 3]. Readers of this issue will find an original article on the mapping of ICD-10 allergic and hypersensitivity conditions in the ICD-11 beta phase structure [1]. Readers of this issue will also find a review article on allergenspecific immunotherapy in pediatric allergic asthma [4] and an original article on the mixed house dust mite and weed pollen extract immunotherapy [5]. Immunotherapy with a history of more than 100 years still works for allergy patients. As radiocontrast media (RCM) media induced hypersensitivity is an unpredictable adverse drug reaction, prevention of the recurrence is one of the key components of the management [6]. Avoidance is the best if possible. When you order computed tomography scans using RCM, it is important to find out those who had a history of RCM induced hypersensitivity reactions. A clinical decision supporting system embedded in the electronic medical record system may help [7]. If it is impossible to avoid